A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact ...

Metabolism-targeting injections could pave the way for a new treatments, detection and prevention of bowel cancer ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

A team of ophthalmology researchers at Stanford University, working with a colleague from New York University School of Medicine ... the group analyzed patient data on millions of diabetics and the ...

While these new findings showed improvements in HbA1c ... “It’s clear from today’s discussion that an FDA-approved treatment and clear education on managing risk is urgently needed, and we believe our ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Diabetes costs US employers over $106B in lost productivity. Learn how data-driven support can improve employee health and ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...